UNSPSC 51392226: Metizoline hydrochloride

This classification denotes an adrenergic agonist with the molecular formula C13H14N2S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PU364U720Z, chemically known as 4,5-dihydro-2-((2-methylbenzo(b)thien-3-yl)methyl)-1h-imidazole monohydrochloride but more generally known as metizoline hydrochloride, which bears US NIH Compound Identifier 68629. Most nations, for tariff and trade purposes, schedule metizoline hydrochloride under HS 29349990 and SITC 51579.

As of Q4 2014, METIZOLINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Metizoline hydrochloride bears US NLM identifiers UMLS ID C2983811 and NCI Concept Code C90632. SMILES: CC1C(C2CCCCC2S1)CC3=NCCN3.CL.

UNSPSC 51392226 Metizoline hydrochloride is a Commodity code tracking pharmaceutical products, though the recent state and local procurement activity under this code reflects a mismatch between the nominal product name and actual buying patterns. Seminole County, Florida's recent solicitation (IFB60459723LAS, posted June 30, 2026, response due July 26, 2023) sought naloxone and safe drug deactivation systems rather than metizoline hydrochloride specifically, indicating that state and local jurisdictions may be using this code as a catch-all for emergency pharmaceutical and harm-reduction supplies. The scope includes both the pharmaceutical product itself and ancillary systems or kits, with delivery and logistics integrated into vendor proposals. Issuing bodies appear limited to county health departments and community health programs based on available recent activity.

The geographic footprint shows Florida county activity in the recent record, with Seminole County's procurement requiring quarterly deliveries to a specified health facility and annual volumes of 1,900 units of naloxone and 800 deactivation systems. Vendors must meet standard state and local compliance requirements including E-Verify certification, drug-free workplace attestation, and specified insurance coverage (workers' compensation, commercial general liability, and professional liability). The contract structure includes a two-year initial term with one-year renewal option and a three-month probationary termination period at the county's discretion. FEMA funding was noted as a potential source, introducing federal compliance overlay (Clean Air Act and Federal Water Pollution Control Act adherence). No set-aside designations appear in the Seminole County record. The mismatch between the code's nominal pharmaceutical name and the actual procurement scope suggests limited recent activity directly aligned with metizoline hydrochloride as specified.